Background -The clinical value of computed tomographic (CT) scanning of the chest in the initial assessment of sarcoidosis was investigated. Methods -One hundred consecutive patients referred to the sarcoidosis outpatient services of the Mount Sinai Medical Center, New York from 1990 to 1992 with a presumptive diagnosis of sarcoidosis were studied. The diagnosis was subsequently confirmed in all by a positive tissue biopsy sample or the KveimSiltzbach test. Clinical and laboratory data of each patient were reviewed. Chest radiographs were classified according to the classical stages of sarcoidosis. Thirty five of the 100 patients had a CT scan of the chest performed before presentation. The CT scans were compared with the presenting clinical data and standard chest radiographs in order to determine if they yielded useful additional information regarding diagnosis or treatment. Results -The chest CT scan revealed no additional clinically relevant information compared with conventional chest radiographs in any of the 35 studies performed. In two patients mediastinal adenopathy was detected by CT scan which was not seen on standard radiographs. Two patients thought to exhibit hilar adenopathy and pulmonary infiltrations by standard radiography had no parenchymal disease on the CT scan. Bilateral parenchymal infiltrates were seen in one patient which were interpreted as unilateral infiltrates by standard radiographs. The variance between conventional radiographs and CT scans in these five patients was not clinically valuable. Conclusions -CT scans ofthe chest do not add clinically useful information to the standard chest radiographs in the initial assessment of sarcoidosis in patients presenting with the typical standard radiological patterns. CT scanning ofthe thorax is indicated in patients with proven or suspected sarcoidosis when the standard chest radiographs are normal or not typical of sarcoidosis, when signs or symptoms of upper airway obstruction are present, when the patient has haemoptysis, if there is a suspicion of a complicating second intrathoracic disease, or the patient is a candidate for lung transplantation.
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Although studies of low dose CT scans are in progress, the current standard CT scan exposes patients to 0-04-0-14 Gy.2122 High resolution CT scanning delivers a significantly greater dose of radiation. The minimal information obtained, the additional radiation, and the extra financial burden place a major responsibility on the treating physician to have precise indications for ordering a CT scan of the thorax in a patient presenting with a typical standard chest radiograph of sarcoidosis.
This study is not meant to preclude the use of CT scans in all patients with sarcoidosis. We propose the following indications for thoracic high resolution CT scanning of the thorax in patients undergoing study for suspected or proven sarcoidosis: (1) normal standard chest radiograph; (2) standard chest radiograph atypical for sarcoidosis; (3) haemoptysis in a patient with proven sarcoidosis; (4) suspicion of a second complicating disease (for example, pulmonary neoplasm, infection or pleural process); and (5) candidates for lung transplantation.
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